90 related articles for article (PubMed ID: 20715986)
1. Prokaryotic expression of Stx1B subunit of Escherichia coli O157:H7 used to generate monoclonal antibody.
Li G; Hong J; Ren X; Yin J; Feng S; Huo G
Hybridoma (Larchmt); 2010 Aug; 29(4):283-9. PubMed ID: 20715986
[TBL] [Abstract][Full Text] [Related]
2. Enhanced immunogenicity of a novel Stx2Am-Stx1B fusion protein in a mice model of enterohemorrhagic Escherichia coli O157:H7 infection.
Cai K; Gao X; Li T; Wang Q; Hou X; Tu W; Xiao L; Tian M; Liu Y; Wang H
Vaccine; 2011 Jan; 29(5):946-52. PubMed ID: 21134452
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies against Stx1B subunit of Escherichia coli O157:H7 distinguish the bacterium from other bacteria.
Li G; Hong J; Huo G; Ren X
Lett Appl Microbiol; 2010 Nov; 51(5):499-503. PubMed ID: 20854398
[TBL] [Abstract][Full Text] [Related]
4. Subcutaneous and intranasal immunization with Stx2B-Tir-Stx1B-Zot reduces colonization and shedding of Escherichia coli O157:H7 in mice.
Zhang XH; He KW; Zhang SX; Lu WC; Zhao PD; Luan XT; Ye Q; Wen LB; Li B; Guo RL; Wang XM; Lv LX; Zhou JM; Yu ZY; Mao AH
Vaccine; 2011 May; 29(22):3923-9. PubMed ID: 21338683
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of a novel Stx2B-Stx1B fusion protein in a mice model of Enterohemorrhagic Escherichia coli O157:H7 infection.
Gao X; Cai K; Shi J; Liu H; Hou X; Tu W; Xiao L; Wang Q; Wang H
Vaccine; 2009 Mar; 27(14):2070-6. PubMed ID: 19428832
[TBL] [Abstract][Full Text] [Related]
6. Novel fusion antigen displayed-bacterial ghosts vaccine candidate against infection of Escherichia coli O157:H7.
Cai K; Tu W; Liu Y; Li T; Wang H
Sci Rep; 2015 Dec; 5():17479. PubMed ID: 26626573
[TBL] [Abstract][Full Text] [Related]
7. Characterization of monoclonal immunoglobulin a and g against shiga toxin binding subunits produced by intranasal immunization.
Tanikawa T; Ishikawa T; Maekawa T; Kuronane K; Imai Y
Scand J Immunol; 2008 Oct; 68(4):414-22. PubMed ID: 18782271
[TBL] [Abstract][Full Text] [Related]
8. [Expression and identification of enterohemorrhagic Escherichia coli O157:H7 Shiga toxin1A subunit].
Huang M; Zeng X; Shi F; Zhang L; Li X; Jiao Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Feb; 30(2):121-4. PubMed ID: 24491048
[TBL] [Abstract][Full Text] [Related]
9. Engineering an anti-Stx2 antibody to control severe infections of EHEC O157:H7.
Ma Y; Mao X; Li J; Li H; Feng Y; Chen H; Luo P; Gu J; Yu S; Zeng H; Guo G; Yang K; Zou Q
Immunol Lett; 2008 Dec; 121(2):110-5. PubMed ID: 19007817
[TBL] [Abstract][Full Text] [Related]
10. Novel fusion protein protects against adherence and toxicity of enterohemorrhagic Escherichia coli O157:H7 in mice.
Gao X; Cai K; Li T; Wang Q; Hou X; Tian R; Liu H; Tu W; Xiao L; Fang L; Luo S; Liu Y; Wang H
Vaccine; 2011 Sep; 29(38):6656-63. PubMed ID: 21742003
[TBL] [Abstract][Full Text] [Related]
11. [Construction and immunization of a enterohemorrhagic Escherichia coli O157 attenuated].
Liu J; Sun Y; Feng SZ
Sheng Wu Gong Cheng Xue Bao; 2007 Mar; 23(2):211-7. PubMed ID: 17460890
[TBL] [Abstract][Full Text] [Related]
12. Delivery of heterologous protein antigens via hemolysin or autotransporter systems by an attenuated ler mutant of rabbit enteropathogenic Escherichia coli.
Zhu C; Ruiz-Perez F; Yang Z; Mao Y; Hackethal VL; Greco KM; Choy W; Davis K; Butterton JR; Boedeker EC
Vaccine; 2006 May; 24(18):3821-31. PubMed ID: 16098637
[TBL] [Abstract][Full Text] [Related]
13. [Preparation and characterization of monoclonal antibody against Enterohemorrhagic Escherichia coli O157:H7 EspA].
Yu S; Luo P; Chen HZ; Li HX; Mao XH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jul; 23(7):657-9. PubMed ID: 17618593
[TBL] [Abstract][Full Text] [Related]
14. B-cell epitope KT-12 of enterohemorrhagic Escherichia coli O157:H7: a novel peptide vaccine candidate.
Wan CS; Zhou Y; Yu Y; Peng LJ; Zhao W; Zheng XL
Microbiol Immunol; 2011 Apr; 55(4):247-53. PubMed ID: 21272063
[TBL] [Abstract][Full Text] [Related]
15. The role of virulence factors in enterohemorrhagic Escherichia coli (EHEC)--associated hemolytic-uremic syndrome.
Karch H
Semin Thromb Hemost; 2001 Jun; 27(3):207-13. PubMed ID: 11446654
[TBL] [Abstract][Full Text] [Related]
16. The effect of probiotic treatment with Clostridium butyricum on enterohemorrhagic Escherichia coli O157:H7 infection in mice.
Takahashi M; Taguchi H; Yamaguchi H; Osaki T; Komatsu A; Kamiya S
FEMS Immunol Med Microbiol; 2004 Jul; 41(3):219-26. PubMed ID: 15196571
[TBL] [Abstract][Full Text] [Related]
17. Production and characterisation of monoclonal antibodies to Verotoxins 1 and 2 from Escherichia coli of serotype O 157:H7.
Padhye VV; Zhao T; Doyle MP
J Med Microbiol; 1989 Nov; 30(3):219-26. PubMed ID: 2479749
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity of recombinant porcine attaching and effacing-associated protein compared with intimin fragment in Escherichia coli O157:H7-infected mice.
Li T; Han R; Wang Q; Wang S; Fang H; Li Z; Tu W; Wang D; Wang H
Foodborne Pathog Dis; 2013 Dec; 10(12):1016-22. PubMed ID: 24093308
[TBL] [Abstract][Full Text] [Related]
19. The serine 31 residue of the B subunit of Shiga toxin 2 is essential for secretion in enterohemorrhagic Escherichia coli.
Shimizu T; Kawakami S; Sato T; Sasaki T; Higashide M; Hamabata T; Ohta T; Noda M
Infect Immun; 2007 May; 75(5):2189-200. PubMed ID: 17325057
[TBL] [Abstract][Full Text] [Related]
20. Towards an attenuated enterohemorrhagic Escherichia coli O157:H7 vaccine characterized by a deleted ler gene and containing apathogenic Shiga toxins.
Liu J; Sun Y; Feng S; Zhu L; Guo X; Qi C
Vaccine; 2009 Oct; 27(43):5929-35. PubMed ID: 19682616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
